Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.
You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE), Inozyme Pharma (NASDAQ:INZY) and Citius Oncology (NASDAQ:CTOR).
Pyxis Oncology has a consensus price target of $10.56.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $1.53 last updated January 21, 2025 at 4:00 PM EST.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.